29 May 2024
AGM and GM Meetings
Set for 10:30 AM at Fieldfisher LLP, Riverbank House, 2 Swan Lane, London, EC4R 3TT
23 May 2024
AGM and GM Form of Proxy Votes Due
Vote through your Nominee Account Holder
23 May 2024
AGM and GM Form of Direction Votes Due
13 May 2024
Proposed Reverse Takeover Announced
Publication of Admission Document (Extruded Pharmaceuticals LTD)
10 May 2024
Release of Year End 2023 Financial Audit
Last reporting date for Amur’s 2023 Financial Audit.
25 January 2024
Reverse Takeover Heads of Terms Agreed
Close of 2023 Financial Year.
29 December 2023
Financial Year End
Close of 2023 Financial Year.
30 November 2023
Annual General Meeting
All resolutions passed
13 November 2023
Notice of Annual General Meeting
Scheduled for 30 November 2023
25 September 2023
Mid-Year 2023 Financial Review Released
For period ending 30 June 2023
07 September 2023
Suspension of Trading on AIM
30 June 2023
Deadline For Release of 2022 Financial Audit
Last reporting date for Amur’s 2022 Financial Audit.
30 June 2023
End of Mid-Year H1 Financial Period
Close of H1 2023 Financial Year.
30 June 2023
2022 Year End Financial Statement Issued
Closing Date 31 December 2022
14 June 2023
Dividend Payment
For payment of the dividend. As the source of the funds were Russian Federation based, shareholders are required to register a mandate directly with Link Registrars to receive payment.
1 June 2023
Ex-Dividend Date
Shareholders of record at close of business 2 June 2023 will be entitled to payment of the dividend set for payment 14 June 2023.
24 May 2023
Dividend Declaration
Shareholders of record at close of business 2 June 2023 will be entitled to payment of the dividend set for payment 14 June 2023.